Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Lightweight and Explainable AI Framework Toward Automated Infraocclusion Detection in Pediatric Panoramic Radiographs.

Diagnostics (Basel, Switzerland)·2026
Same author

Advanced Brain Tumor Classification in MR Images Using Transfer Learning and Pre-Trained Deep CNN Models.

Cancers·2025
Same author

Learning from Imbalanced Data: Integration of Advanced Resampling Techniques and Machine Learning Models for Enhanced Cancer Diagnosis and Prognosis.

Cancers·2024
Same author

Effects of Sandbag-Free Follow-up After Manual Compression in Patients Who Underwent Transfemoral Access for Percutaneous Intervention.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2024
Same author

The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H<sub>2</sub> FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction.

Journal of clinical ultrasound : JCU·2023
Same author

Machine learning based assessment of preclinical health questionnaires.

International journal of medical informatics·2023
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

637

Synthetic Boosted Resampling Using Deep Generative Adversarial Networks: A Novel Approach to Improve Cancer

Fatih Gurcan1, Ahmet Soylu2

  • 1Department of Management Information Systems, Faculty of Economics and Administrative Sciences, Karadeniz Technical University, 61080 Trabzon, Turkey.

Cancers
|December 17, 2024
PubMed
Summary
This summary is machine-generated.

Generative Adversarial Networks (GANs) significantly improve imbalanced healthcare data classification. GAN-based resampling enhances minority class detection and overall model performance, especially with Boosting classifiers.

Keywords:
Generative Adversarial Networks (GANs)ROC AUCbagging and boosting modelscancer diagnosis and prognosisclass imbalanceresampling strategies

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

637
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Area of Science:

  • Machine Learning in Healthcare
  • Data Science
  • Medical Informatics

Background:

  • Imbalanced datasets pose significant challenges in critical healthcare applications like cancer diagnosis and prognosis.
  • Traditional resampling methods may not adequately address the complexities of generating realistic synthetic data for minority classes.
  • Effective handling of imbalanced data is crucial for accurate medical diagnoses and prognoses.

Purpose of the Study:

  • To evaluate the effectiveness of Generative Adversarial Networks (GANs) as a resampling method for imbalanced healthcare datasets.
  • To compare the performance of various classifier models (Boosting, Bagging, Linear, Non-linear) when using GAN-generated data.
  • To assess the impact of GAN-based resampling on key performance metrics, including accuracy, precision, recall, F1 score, and ROC AUC.

Main Methods:

  • Generative Adversarial Networks (GANs) were employed to generate synthetic data for the minority class, addressing class imbalance.
  • Four distinct classifier types—Boosting, Bagging, Linear, and Non-linear—were evaluated.
  • Performance was rigorously assessed using standard classification metrics, with a focus on Receiver Operating Characteristic Area Under the Curve (ROC AUC).

Main Results:

  • Baseline classification without resampling demonstrated significant performance limitations.
  • GAN-based resampling substantially improved the detection of minority instances and overall classification accuracy.
  • Average ROC AUC increased from approximately 0.8276 to over 0.9734, with the GradientBoosting classifier achieving the highest ROC AUC of 0.9890.

Conclusions:

  • Generative Adversarial Networks (GANs) represent a powerful strategy for resampling imbalanced healthcare datasets.
  • Advanced classifier models, particularly Boosting and Bagging, show superior performance when combined with GAN-based resampling.
  • The study confirms the efficacy of GANs in enhancing predictive accuracy for critical healthcare applications.